Johnson & Johnson First To Enter Final Trial Stage For A Single-Dose Vaccine
Four COVID-19 experimental vaccines are now in Phase 3 of clinical trial testing, but Johnson & Johnson's candidate is the only one that could be delivered in one shot instead of two.